| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme activity | 1.63e-05 | 43 | 71 | 4 | GO:0061650 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme activity | 3.07e-04 | 37 | 71 | 3 | GO:0061631 | |
| GeneOntologyBiologicalProcess | sensory neuron axon guidance | 3.60e-05 | 3 | 72 | 2 | GO:0097374 | |
| GeneOntologyBiologicalProcess | purine-containing compound salvage | 5.99e-05 | 22 | 72 | 3 | GO:0043101 | |
| Domain | UQ_con | 4.18e-04 | 39 | 70 | 3 | PF00179 | |
| Domain | UBIQUITIN_CONJUGAT_1 | 4.51e-04 | 40 | 70 | 3 | PS00183 | |
| Domain | UBQ-conjugat_E2 | 4.85e-04 | 41 | 70 | 3 | IPR000608 | |
| Domain | UBIQUITIN_CONJUGAT_2 | 4.85e-04 | 41 | 70 | 3 | PS50127 | |
| Domain | Clathrin_mu | 6.11e-04 | 10 | 70 | 2 | IPR001392 | |
| Domain | Adap_comp_sub | 7.45e-04 | 11 | 70 | 2 | PF00928 | |
| Domain | MHD | 1.05e-03 | 13 | 70 | 2 | PS51072 | |
| Domain | MHD | 1.05e-03 | 13 | 70 | 2 | IPR028565 | |
| Domain | EPHD | 3.05e-03 | 22 | 70 | 2 | PS51805 | |
| Domain | Cadherin_cytoplasmic-dom | 3.93e-03 | 25 | 70 | 2 | IPR000233 | |
| Domain | Cadherin_C | 3.93e-03 | 25 | 70 | 2 | PF01049 | |
| Domain | PHD | 4.55e-03 | 89 | 70 | 3 | SM00249 | |
| Domain | Znf_PHD | 4.84e-03 | 91 | 70 | 3 | IPR001965 | |
| Domain | Catenin_binding_dom | 5.27e-03 | 29 | 70 | 2 | IPR027397 | |
| Domain | - | 5.27e-03 | 29 | 70 | 2 | 4.10.900.10 | |
| Domain | ZF_PHD_2 | 5.46e-03 | 95 | 70 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 5.62e-03 | 96 | 70 | 3 | PS01359 | |
| Pubmed | CEP350 RAP1GAP UBE2O DAZAP1 UBE2I UBE4B SBNO1 RBL2 TRPS1 IST1 MAGI3 TOP1 AFF4 | 2.10e-06 | 1285 | 72 | 13 | 35914814 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 31541021 | ||
| Pubmed | DAZAP1 HNRNPUL2 UBE2V1 USO1 UBAP2L CGN PHRF1 IST1 HDGFL2 TOP1 | 4.97e-06 | 786 | 72 | 10 | 29128334 | |
| Pubmed | 8.15e-06 | 653 | 72 | 9 | 22586326 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GMPS KMT2C PPP2R3A DAZAP1 UBE4B UBAP2L TRPS1 ETV1 ZFHX2 MAGI3 ATP8B1 PRKAG2 AFF4 | 1.04e-05 | 1489 | 72 | 13 | 28611215 |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 17391059 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 10759568 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 12213813 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.89e-05 | 398 | 72 | 7 | 35016035 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | GMPS UBE2O UBE2I RNPEP USO1 UBAP2L TAB2 MORC4 GCN1 HDGFL2 TOP1 | 2.33e-05 | 1149 | 72 | 11 | 35446349 |
| Pubmed | Development of a high-throughput screen to detect inhibitors of TRPS1 sumoylation. | 2.53e-05 | 4 | 72 | 2 | 23772552 | |
| Pubmed | TAB2, an important upstream adaptor of interleukin-1 signaling pathway, is subject to SUMOylation. | 2.53e-05 | 4 | 72 | 2 | 24096733 | |
| Pubmed | 2.55e-05 | 417 | 72 | 7 | 36537216 | ||
| Pubmed | Molecular signatures and cellular diversity during mouse habenula development. | 2.69e-05 | 28 | 72 | 3 | 35793630 | |
| Pubmed | Motor neuron position and topographic order imposed by β- and γ-catenin activities. | 2.99e-05 | 29 | 72 | 3 | 22036570 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 3.19e-05 | 432 | 72 | 7 | 23455922 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GMPS SEC24D UBE2O UBE2I UBE4B SBNO1 HNRNPUL2 UBE2V1 RPS6KA1 IST1 GCN1 HDGFL2 | 4.12e-05 | 1455 | 72 | 12 | 22863883 |
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 23601649 | ||
| Pubmed | GMPS BROX TCF20 UBE2I RNPEP SBNO1 HNRNPUL2 TRPS1 HDGFL2 TOP1 | 4.43e-05 | 1014 | 72 | 10 | 32416067 | |
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 21512569 | ||
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 12569367 | ||
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 21575904 | ||
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 12917345 | ||
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 21866272 | ||
| Pubmed | Antiviral immunity: TRIM5 moonlights as a pattern recognition receptor. | 6.31e-05 | 6 | 72 | 2 | 21572451 | |
| Pubmed | 6.42e-05 | 202 | 72 | 5 | 29540532 | ||
| Pubmed | 6.81e-05 | 38 | 72 | 3 | 31597102 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 7.07e-05 | 861 | 72 | 9 | 36931259 | |
| Pubmed | 7.54e-05 | 209 | 72 | 5 | 36779422 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.71e-05 | 341 | 72 | 6 | 32971831 | |
| Pubmed | Transcriptional Networks Controlled by NKX2-1 in the Development of Forebrain GABAergic Neurons. | 7.95e-05 | 40 | 72 | 3 | 27657450 | |
| Pubmed | Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. | 8.57e-05 | 41 | 72 | 3 | 15561718 | |
| Pubmed | Three-axis classification of mouse lung mesenchymal cells reveals two populations of myofibroblasts. | 8.82e-05 | 7 | 72 | 2 | 35302583 | |
| Pubmed | 8.82e-05 | 7 | 72 | 2 | 21245381 | ||
| Pubmed | The serine/arginine-rich protein SF2/ASF regulates protein sumoylation. | 8.82e-05 | 7 | 72 | 2 | 20805487 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 9.59e-05 | 220 | 72 | 5 | 35785414 | |
| Pubmed | A genome-wide association study of the Protein C anticoagulant pathway. | 1.17e-04 | 8 | 72 | 2 | 22216198 | |
| Pubmed | 1.17e-04 | 8 | 72 | 2 | 11551945 | ||
| Pubmed | 1.50e-04 | 242 | 72 | 5 | 34011540 | ||
| Pubmed | Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily. | 1.51e-04 | 9 | 72 | 2 | 17512525 | |
| Pubmed | TRIM5 is an innate immune sensor for the retrovirus capsid lattice. | 1.51e-04 | 9 | 72 | 2 | 21512573 | |
| Pubmed | 1.51e-04 | 9 | 72 | 2 | 26305926 | ||
| Pubmed | 1.51e-04 | 9 | 72 | 2 | 16940173 | ||
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 1.68e-04 | 248 | 72 | 5 | 27926873 | |
| Pubmed | 2.20e-04 | 263 | 72 | 5 | 34702444 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 2.63e-04 | 607 | 72 | 7 | 39147351 | |
| Pubmed | 2.75e-04 | 12 | 72 | 2 | 25007825 | ||
| Pubmed | Direct activation of protein kinases by unanchored polyubiquitin chains. | 3.25e-04 | 13 | 72 | 2 | 19675569 | |
| Pubmed | 3.25e-04 | 13 | 72 | 2 | 24723342 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 3.36e-04 | 1061 | 72 | 9 | 33845483 | |
| Pubmed | 3.55e-04 | 638 | 72 | 7 | 31182584 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 3.58e-04 | 1070 | 72 | 9 | 23533145 | |
| Pubmed | 3.71e-04 | 67 | 72 | 3 | 29254152 | ||
| Pubmed | 3.78e-04 | 14 | 72 | 2 | 9179496 | ||
| Pubmed | Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse. | 3.78e-04 | 14 | 72 | 2 | 20847152 | |
| Pubmed | 4.29e-04 | 469 | 72 | 6 | 27634302 | ||
| Pubmed | TRIM28 functions as the SUMO E3 ligase for PCNA in prevention of transcription induced DNA breaks. | 4.36e-04 | 15 | 72 | 2 | 32900933 | |
| Pubmed | 4.36e-04 | 15 | 72 | 2 | 33833667 | ||
| Pubmed | A neurogenomics approach to gene expression analysis in the developing brain. | 4.38e-04 | 170 | 72 | 4 | 15582152 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 4.69e-04 | 477 | 72 | 6 | 31300519 | |
| Pubmed | 4.96e-04 | 74 | 72 | 3 | 15276183 | ||
| Pubmed | TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. | 4.98e-04 | 16 | 72 | 2 | 15327770 | |
| Pubmed | 5.18e-04 | 486 | 72 | 6 | 20936779 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 5.31e-04 | 179 | 72 | 4 | 36261009 | |
| Pubmed | 5.46e-04 | 491 | 72 | 6 | 22623428 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 5.48e-04 | 321 | 72 | 5 | 32098917 | |
| Pubmed | 5.58e-04 | 493 | 72 | 6 | 15368895 | ||
| Pubmed | 5.63e-04 | 17 | 72 | 2 | 19690890 | ||
| Pubmed | Nova2 regulates neuronal migration through an RNA switch in disabled-1 signaling. | 5.63e-04 | 17 | 72 | 2 | 20620871 | |
| Pubmed | Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. | 5.79e-04 | 78 | 72 | 3 | 16236267 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 5.88e-04 | 498 | 72 | 6 | 36634849 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 5.91e-04 | 695 | 72 | 7 | 23602568 | |
| Pubmed | 6.33e-04 | 18 | 72 | 2 | 24528677 | ||
| Pubmed | Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract. | 6.33e-04 | 18 | 72 | 2 | 27695001 | |
| Pubmed | 6.33e-04 | 18 | 72 | 2 | 26509897 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 6.50e-04 | 1415 | 72 | 10 | 28515276 | |
| Pubmed | 6.53e-04 | 707 | 72 | 7 | 19738201 | ||
| Pubmed | 6.59e-04 | 708 | 72 | 7 | 39231216 | ||
| Pubmed | 6.64e-04 | 335 | 72 | 5 | 15741177 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | UBE2O DAZAP1 RNPEP SBNO1 HNRNPUL2 USO1 UBAP2L KIAA0586 GCN1 TOP1 | 6.86e-04 | 1425 | 72 | 10 | 30948266 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 6.89e-04 | 934 | 72 | 8 | 33916271 | |
| Pubmed | PTK2B RAP1GAP UBE2O RNPEP HNRNPUL2 USO1 UBAP2L AJM1 PRKAG2 TOP1 | 7.09e-04 | 1431 | 72 | 10 | 37142655 | |
| Pubmed | 7.84e-04 | 20 | 72 | 2 | 17460091 | ||
| Pubmed | 8.65e-04 | 21 | 72 | 2 | 24157949 | ||
| Pubmed | Dlx transcription factors promote migration through repression of axon and dendrite growth. | 8.65e-04 | 21 | 72 | 2 | 17582329 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 8.83e-04 | 357 | 72 | 5 | 37059091 | |
| Pubmed | 8.88e-04 | 1215 | 72 | 9 | 15146197 | ||
| Pubmed | 9.50e-04 | 22 | 72 | 2 | 19820705 | ||
| Pubmed | 9.50e-04 | 22 | 72 | 2 | 22797923 | ||
| Pubmed | 9.50e-04 | 22 | 72 | 2 | 33821423 | ||
| Pubmed | 9.75e-04 | 549 | 72 | 6 | 38280479 | ||
| Pubmed | Functional synergy between cholecystokinin receptors CCKAR and CCKBR in mammalian brain development. | 1.04e-03 | 23 | 72 | 2 | 25875176 | |
| Pubmed | A semaphorin code defines subpopulations of spinal motor neurons during mouse development. | 1.13e-03 | 24 | 72 | 2 | 15869472 | |
| Pubmed | 1.23e-03 | 101 | 72 | 3 | 10997877 | ||
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 1.23e-03 | 101 | 72 | 3 | 24613305 | |
| Pubmed | 1.24e-03 | 225 | 72 | 4 | 12168954 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.24e-03 | 1024 | 72 | 8 | 24711643 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | 1.30e-03 | 1031 | 72 | 8 | 16710414 | |
| Pubmed | Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring. | 1.33e-03 | 26 | 72 | 2 | 39152101 | |
| Pubmed | 1.33e-03 | 26 | 72 | 2 | 19749747 | ||
| Interaction | PAX9 interactions | 6.52e-06 | 130 | 71 | 6 | int:PAX9 | |
| Interaction | AR interactions | GMPS KMT2C TCF20 DAZAP1 UBE2I HNRNPUL2 UBAP2L RPS6KA1 CGN TRPS1 TAB2 MORC4 GCN1 AFF4 | 7.80e-06 | 992 | 71 | 14 | int:AR |
| Interaction | ERG interactions | 1.35e-05 | 223 | 71 | 7 | int:ERG | |
| Cytoband | 7q36.1 | 2.21e-04 | 74 | 72 | 3 | 7q36.1 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 9.35e-05 | 41 | 39 | 3 | 102 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-06 | 175 | 72 | 5 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-06 | 175 | 72 | 5 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.12e-05 | 181 | 72 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 186 | 72 | 5 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.38e-05 | 189 | 72 | 5 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.42e-05 | 190 | 72 | 5 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.45e-05 | 191 | 72 | 5 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-05 | 192 | 72 | 5 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 194 | 72 | 5 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 195 | 72 | 5 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-05 | 197 | 72 | 5 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-05 | 197 | 72 | 5 | 42e49a8ce3118db6c2fd620d70c480b75143c828 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-05 | 199 | 72 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.77e-05 | 199 | 72 | 5 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | PBMC-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 1.11e-04 | 153 | 72 | 4 | db1a6914f2033fb0748e0523cffe5d6dc4e901be | |
| ToppCell | NS-critical-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.66e-04 | 170 | 72 | 4 | adf73bdc049d508f8873c22539db2ca92052a97b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-04 | 174 | 72 | 4 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-04 | 174 | 72 | 4 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 2.02e-04 | 179 | 72 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.15e-04 | 182 | 72 | 4 | 93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 182 | 72 | 4 | d568a8aec7e27ce632e248baea2ccd0e8dd255ac | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.15e-04 | 182 | 72 | 4 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 182 | 72 | 4 | e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 182 | 72 | 4 | 82ca6d5ed48b4c487ce00b9309255abb8f20b61d | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 2.20e-04 | 183 | 72 | 4 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.20e-04 | 183 | 72 | 4 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 183 | 72 | 4 | 1464b5c4425e8776c4aeb4d2b560481d4bf13931 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 2.20e-04 | 183 | 72 | 4 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-04 | 184 | 72 | 4 | af6522586d012e91241f3e06c60f9d1881e95646 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-04 | 184 | 72 | 4 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.24e-04 | 184 | 72 | 4 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.24e-04 | 184 | 72 | 4 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-04 | 184 | 72 | 4 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 184 | 72 | 4 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.29e-04 | 185 | 72 | 4 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-04 | 185 | 72 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.29e-04 | 185 | 72 | 4 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.34e-04 | 186 | 72 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 186 | 72 | 4 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 2.34e-04 | 186 | 72 | 4 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | 21-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 2.34e-04 | 186 | 72 | 4 | f8cddad28896f0edf10a8645fa49a011b22b120d | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.38e-04 | 187 | 72 | 4 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.38e-04 | 187 | 72 | 4 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 188 | 72 | 4 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.43e-04 | 188 | 72 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.43e-04 | 188 | 72 | 4 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.43e-04 | 188 | 72 | 4 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 188 | 72 | 4 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 189 | 72 | 4 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 189 | 72 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 2.48e-04 | 189 | 72 | 4 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 189 | 72 | 4 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 2.48e-04 | 189 | 72 | 4 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 2.48e-04 | 189 | 72 | 4 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 189 | 72 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-04 | 190 | 72 | 4 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.53e-04 | 190 | 72 | 4 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.53e-04 | 190 | 72 | 4 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 190 | 72 | 4 | e2481bd5166fde2cdc0c3824894f2bccb8294fdd | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.58e-04 | 191 | 72 | 4 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.58e-04 | 191 | 72 | 4 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.58e-04 | 191 | 72 | 4 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.58e-04 | 191 | 72 | 4 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 191 | 72 | 4 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.58e-04 | 191 | 72 | 4 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.64e-04 | 192 | 72 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.64e-04 | 192 | 72 | 4 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 2.64e-04 | 192 | 72 | 4 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.64e-04 | 192 | 72 | 4 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.69e-04 | 193 | 72 | 4 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.69e-04 | 193 | 72 | 4 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 2.69e-04 | 193 | 72 | 4 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.69e-04 | 193 | 72 | 4 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-04 | 193 | 72 | 4 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.69e-04 | 193 | 72 | 4 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.74e-04 | 194 | 72 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-04 | 194 | 72 | 4 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.74e-04 | 194 | 72 | 4 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-04 | 194 | 72 | 4 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.74e-04 | 194 | 72 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 2.74e-04 | 194 | 72 | 4 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.74e-04 | 194 | 72 | 4 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 2.80e-04 | 195 | 72 | 4 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | (7)_Epithelial-A_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.80e-04 | 195 | 72 | 4 | c9a6c65ee18d83bf34a4713d306a6e30db1325c2 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.80e-04 | 195 | 72 | 4 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.80e-04 | 195 | 72 | 4 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.85e-04 | 196 | 72 | 4 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | (7)_Epithelial-B_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.85e-04 | 196 | 72 | 4 | 345d4cc062b43bca9d506fbf23363469a9ba496f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-04 | 196 | 72 | 4 | a6a52cafd7c9994bc3d2f68b15a1491cd96ef908 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.91e-04 | 197 | 72 | 4 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 197 | 72 | 4 | f3ca63c7902d7530a29a85eb54f69b303031d150 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 197 | 72 | 4 | f98720cab066579fdac3ba24fb6fe4c5759dae4e | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.91e-04 | 197 | 72 | 4 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | ASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.96e-04 | 198 | 72 | 4 | ec0d1801363adb70c6a26655b79d12b438c7417d | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.96e-04 | 198 | 72 | 4 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 198 | 72 | 4 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 198 | 72 | 4 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.96e-04 | 198 | 72 | 4 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-04 | 198 | 72 | 4 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; PC3; HG-U133A | 2.63e-06 | 196 | 71 | 7 | 1939_DN | |
| Disease | C-reactive protein measurement | ZNF469 RAP1GAP UBE4B SBNO1 RPS6KA1 TRPS1 GBX1 GCN1 CDH4 TOP1 AFF4 | 9.17e-05 | 1206 | 68 | 11 | EFO_0004458 |
| Disease | Fetal Alcohol Spectrum Disorders | 4.02e-04 | 13 | 68 | 2 | C2985290 | |
| Disease | bilirubin measurement | 5.46e-04 | 442 | 68 | 6 | EFO_0004570 | |
| Disease | reticulocyte count | 6.40e-04 | 1045 | 68 | 9 | EFO_0007986 | |
| Disease | Fetal Alcohol Syndrome | 6.96e-04 | 17 | 68 | 2 | C0015923 | |
| Disease | Bone Diseases, Developmental | 1.77e-03 | 27 | 68 | 2 | C0005941 | |
| Disease | Sezary Syndrome | 1.77e-03 | 27 | 68 | 2 | C0036920 | |
| Disease | necrotizing enterocolitis | 1.77e-03 | 27 | 68 | 2 | EFO_0003928 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.90e-03 | 28 | 68 | 2 | EFO_0000389, EFO_0000621 | |
| Disease | reticulocyte measurement | 2.85e-03 | 1053 | 68 | 8 | EFO_0010700 | |
| Disease | differentiated thyroid carcinoma | 2.96e-03 | 35 | 68 | 2 | EFO_1002017 | |
| Disease | Malignant neoplasm of breast | 3.21e-03 | 1074 | 68 | 8 | C0006142 | |
| Disease | diabetic retinopathy | 3.86e-03 | 136 | 68 | 3 | EFO_0003770 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPKTVFPFSYQESPP | 101 | Q9UGJ0 | |
| PPIPKEPSNYDFVYD | 711 | Q92556 | |
| EEPPAEPVSFYTQPF | 101 | Q9H4A4 | |
| EGPQPPTAQVYEFPD | 121 | Q9NQ75 | |
| PFTTPPGPTQFFYTE | 271 | C9J069 | |
| YPVFTPPVKKGEDPF | 181 | P23109 | |
| PGEYLVVPSTFEPFK | 481 | A6NHC0 | |
| FGEVTSPLFPKPYPN | 26 | P00736 | |
| SPLFPKPYPNNFETT | 31 | P00736 | |
| KPPTAQPDFPYGQYA | 336 | Q96EP5 | |
| KFAPPVQESFFPPGG | 781 | O43520 | |
| DAFPPSSPLFAEPYK | 26 | Q9UHB7 | |
| TFSYKPPGNFPFITE | 541 | Q08999 | |
| AVFPKDQRGPYPPDV | 2456 | Q8NEZ4 | |
| NFYGTPKPPAEPSPF | 186 | Q5TCQ9 | |
| PYIFQTPEGVPEQPT | 906 | O00533 | |
| PKPEYGDFQPVSSDP | 1046 | Q9HCH0 | |
| SPTPGPFKPCEYLFE | 546 | Q9HBX8 | |
| PFPPQGFKQEYHDPV | 221 | P50549 | |
| ELNFGQKEEPFFPPP | 411 | Q1KMD3 | |
| QKEEPFFPPPEEFVF | 416 | Q1KMD3 | |
| PNGTIESPGFPEKYP | 156 | O60462 | |
| PEFPTVKYPNPEEGK | 286 | Q96G03 | |
| PEPGFPDTDPSQVYS | 1461 | Q9P1Y6 | |
| TFGDKFTPYVGPIIP | 1766 | Q92616 | |
| SAFSGPYKFPFTPPL | 291 | Q9H0R1 | |
| PYKFPFTPPLESFNL | 296 | Q9H0R1 | |
| PFSPVFGTEQPPKYE | 321 | Q06190 | |
| GAVKPPPNKYPIFFF | 31 | Q7Z4V5 | |
| PSFAEPPDAFYGPQE | 106 | Q14549 | |
| VYIFGPPVKEPPTDV | 561 | P49915 | |
| PPVFEPGFYFVEVPE | 386 | Q9HBT6 | |
| DPNIGPYVFELPFVP | 641 | P55283 | |
| TAPPAPAYKGFNPSE | 331 | Q5VT06 | |
| TPFSYPLPKGPSDFN | 241 | P53990 | |
| PVYGPQLEPFEKFPE | 336 | A6NMB9 | |
| DEVTPPDYQPPGFKD | 181 | Q86X24 | |
| EVGYLEFTGPPQKPP | 846 | Q14289 | |
| EFTTPVKDYSPPPVD | 56 | Q12770 | |
| VSPPPDYPGEFFKDV | 1061 | A3KN83 | |
| PQDTSPGPIYFLDPK | 81 | Q3SX64 | |
| KPQPNFPSPEYMIFD | 596 | O60763 | |
| PNLFPFEKEGPHYTP | 166 | Q9NQ50 | |
| FYDNIGFVGPVPPKP | 631 | Q9NYJ8 | |
| QTPTKAPEEPDPFYY | 6 | P58549 | |
| TPPYLFPEYPEASKN | 621 | Q8TE76 | |
| SFPPPLKTEEDYIPY | 16 | P47736 | |
| SLAQPPEAPFVYFKP | 116 | Q8ND83 | |
| PPNPPAFIFMIDVSY | 436 | O94855 | |
| ANYGLVEPIPFEFPP | 346 | Q5VW32 | |
| YFDSFEPGMFPPTPL | 176 | Q8N6S5 | |
| PENPYSQVKGFPAPS | 101 | Q9P2M7 | |
| LFVKFGPPPTASPGY | 146 | Q01973 | |
| SPPGSPIEKYQYPLF | 1081 | Q9UHF7 | |
| KFEPPLFHPNVYPSG | 76 | P63279 | |
| PSTFQYGPAVFPVAP | 921 | Q14157 | |
| PGATPTSPPELFQYF | 621 | Q9C0A1 | |
| IVDFYFSPGPPSNSP | 66 | Q9Y6Q2 | |
| NFPAEYPFKPPRITF | 56 | A0A1B0GUS4 | |
| PFGVPDFPQQPKSHY | 486 | Q5T4T6 | |
| LYGDQPPFSEPKFPT | 741 | O95155 | |
| PEKSGYPDIGFPLFP | 1246 | Q9C0C9 | |
| CGPKYPEAPPFVRFV | 71 | Q13404 | |
| FGEPSYPEVFEPPLT | 331 | P49810 | |
| ISPKQEGFPPKGYFP | 1521 | Q9UGU0 | |
| YDPSVKPPFDIGFEG | 86 | Q8N4Q0 | |
| YQPEPAKAFPFPADG | 661 | Q96JG9 | |
| PPPAYAPTNGDFTFV | 6 | Q9BSR8 | |
| DYPGADIQPNSPPFF | 206 | Q6UXY8 | |
| DIQPNSPPFFGEPDY | 211 | Q6UXY8 | |
| APFPVVSQPSFYSGP | 226 | A5D8V6 | |
| VFAPPYEPLPENVKF | 226 | P11387 | |
| QAGPYSPEKFQPSPL | 851 | Q9ULE0 | |
| ADSTKYNGPPFPPVA | 886 | Q9BVV6 | |
| PPFKPAVAQPDDTFY | 336 | Q15418 | |
| PADYFAPEVQPYPKG | 221 | Q9Y3Q0 | |
| FNPPYVVTPPQEVGS | 121 | Q9Y5N5 |